LAMP1 and COVID-19: Regarding the cytotoxic activity of NK cells in COVID-19, functional impairment, which is founded by either indirect observations such as decline of perforin levels, increase in exhaustion markers, or decreased degranulation, as measured by CD107a expression when PBMCs from COVID-19 patients are cocultured with tumour target cells (19, 28–31).